Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-up-Reference-Cited by-同舟云学术

Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-up

Published:2016-10-21 Issue:1 Volume:176 Page:65-75
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Liu Lifang¹,Giusti Francesco¹,Schaapveld Michael²³,Aleman Berthe⁴,Lugtenburg Pieternella⁵,Meijnders Paul⁶,Hutchings Martin⁷,Lemmens Valery²,Bogaerts Jan¹,Visser Otto²

Affiliation:

1. Department of Statistics; The European Organisation for Research and Treatment of Cancer (EORTC); Brussels Belgium

2. Netherlands Comprehensive Cancer Organisation (IKNL); Utrecht the Netherlands

3. Division of Psychosocial Research and Epidemiology; the Netherlands Cancer Institute (NKI); Amsterdam the Netherlands

4. Department of Radiation Oncology; the Netherlands Cancer Institute (NKI); Amsterdam the Netherlands

5. Department of Hematology; Erasmus MC Cancer Institute; Rotterdam the Netherlands

6. Department of Radiation Oncology; ZNA Middelheim and University of Antwerp; Antwerp Belgium

7. Department of Haematology; Rigshospitalet Copenhagen University Hospital; Copenhagen Denmark

Funder

Sally Snowman Survivorship Fellowship

European Organisation for Research and Treatment of Cancer

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14379/fullpdf

Reference34 articles.

1. Involved-field radiotherapy for advanced Hodgkin's lymphoma;Aleman;New England Journal of Medicine,2003

2. In defense of pharmacoepidemiology-embracing the yin and yang of drug research;Avorn;New England Journal of Medicine,2007

3. How we treat elderly patients with Hodgkin lymphoma;Bjorkholm;Current Opinion in Oncology,2011

4. Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect”;Braunholtz;Journal of Clinical Epidemiology,2001

5. Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group;Carde;Journal of Clinical Oncology,1993

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma;Signal Transduction and Targeted Therapy;2023-09-20

2. Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials;Acta Oncologica;2023-04-11

3. Clinical characteristics of Australian treatment‐naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry;European Journal of Haematology;2022-12-28

4. Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data;European Journal of Haematology;2022-11-25

5. First‐line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes;eJHaem;2022-04-19